Zura Bio: Funding, Investors & Team (Sep 2026)
Zura Bio integrates immunology resources into phase 2 development programs, such as ZB-168 and torudokimab, to provide therapies for patients with autoimmune diseases. ZB-168 is a treatment that targets IL7R and could impact conditions related to IL7 and TSLP pathways. The therapeutic uses of ZB-168 are based on data from phase 1b trials for type 1 diabetes and its profile and biological mechanism. The phase 2 clinical development of torudokimab, a monoclonal antibody that blocks IL33, has also been initiated.
Zura Bio has raised $318M across 3 funding rounds on record, the most recent an undisclosed round of $125M announced in Feb 2026.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Zura Bio Company Profile and Key Stats
Latest funding round on record: Feb 2026.
Zura Bio Funding Rounds
Zura Bio raised $80.0M in an undisclosed round announced in Apr 2023.
1 years later, an undisclosed round of $113M was announced in Apr 2024.
1.8 years later, an undisclosed round of $125M was announced in Feb 2026.
Zura Bio Founders and Leadership Team
No contact details are on record for this team yet.
Zura Bio Funding Compared to Other Biotechnology Startups
Zura Bio's latest round of $125M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Zura Bio in Biotechnology and San Diego
Companies Similar to Zura Bio
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Zura Bio Funding FAQs
What does Zura Bio do?
Zura Bio integrates immunology resources into phase 2 development programs, such as ZB-168 and torudokimab, to provide therapies for patients with autoimmune diseases. ZB-168 is a treatment that targets IL7R and could impact conditions related to IL7 and TSLP pathways. The therapeutic uses of ZB-168 are based on data from phase 1b trials for type 1 diabetes and its profile and biological mechanism. The phase 2 clinical development of torudokimab, a monoclonal antibody that blocks IL33, has also been initiated.
How much funding has Zura Bio raised?
Zura Bio has raised $318M across 3 rounds on record. The most recent is an undisclosed round of $125M announced in Feb 2026.
When did Zura Bio last raise funding?
Zura Bio's most recent funding round on record is an undisclosed round of $125M, announced in Feb 2026.
Who founded Zura Bio?
FundedIQ lists Chris Cabell (Founder), Parisa Faghihi (Founder), Someit Sidhu (Founder) at Zura Bio.
Where is Zura Bio headquartered?
Zura Bio is based in San Diego, California, United States.
How many employees does Zura Bio have?
Zura Bio is in the 11-50 employee band.
How does Zura Bio's funding compare to other Biotechnology startups?
Zura Bio's latest round of $125M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Zura Bio Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Zura Bio is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.